Delivery Order SPE2DR25D1004-SPE2DR26FSWE7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $44,397.25 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is firm fixed-price with no set-aside designation and is scheduled for completion by October 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,440.68 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $11,793.61 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $24,180.49 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on October 31, 2025, with completion scheduled for November 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $8,176.37 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a $18,462.83 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $15,827.33 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion deadline of December 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,522.48 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order, awarded on August 27, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $128,584.18 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on November 25, 2025, with an ultimate completion date of November 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $17,611.34 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 2, 2025. This non-set-aside, firm fixed-price delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken,...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSWE7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,796.37 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, executed on December 8, 2025, with completion targeted for December 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used in cardiovascular disease management for patients requiring cholesterol reduction. This delivery order supports the Defense Health Agency's pharmaceutical supply chain needs across military healthcare systems. AmerisourceBergen has demonstrated consistent capability in meeting federal medical procurement requirements through competitive award processes, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's role as a pharmaceutical prime vendor reflects its critical importance to sustaining military medical operations and supporting beneficiary healthcare needs within the Department of Defense medical supply infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/7/25 |